Wednesday 19 June 2019

Early research shows a way to develop effective therapies against pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, is the fifth most common cause of death from cancer in the UK and the third in the United States. Deaths from PDAC outnumber those from breast cancer despite the significant difference in incidence rates.

* This article was originally published here